FDA Inspection 1311376 — The Procter & Gamble Manufacturing Company
The FDA completed an inspection of The Procter & Gamble Manufacturing Company on Jun 9, 2026 in Greensboro, NC. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 4 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Greensboro, NC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1912 | 21 CFR 211.166(a) | Written program not followed |
| 2027 | 21 CFR 211.192 | Investigations of discrepancies, failures |
| 2397 | 21 CFR 211.194(a)(1) | Description and Identification of Samples |
| 4323 | 21 CFR 211.115(a) | Reprocessing procedures lack steps to be taken |